Stockscreener 앱 받기
21.01
3.22%
-0.70
시간 외 거래:
20.83
-0.18
-0.86%
Schrodinger Inc 주식(SDGR)의 최신 뉴스
Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock - Yahoo
Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505 - MSN
Schrodinger stock rating assumed by Morgan Stanley at Equalweight - Investing.com Nigeria
Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert
Schrödinger (SDGR) Gains FDA Fast Track for MALT1 Inhibitor - GuruFocus
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia | SDGR Stock News - GuruFocus
Schrödinger’s MALT1 inhibitor receives FDA fast track designation - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - PR Newswire
Schrodinger Announces Board Elections and Approvals - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger - Bluefield Daily Telegraph
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Where are the Opportunities in (SDGR) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, ... - Eagle-Tribune
Harbor Capital Advisors Inc. Grows Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results - Seeking Alpha
Schrödinger (SDGR) Shares Dip After Initial Phase 1 Trial Data - GuruFocus
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data fo - GuruFocus
Schrodinger Reports 22% Response Rate in Phase 1 Trial of SGR-1505 for B-Cell Cancers; Shares Fall - MarketScreener
Schrödinger stock slides on cancer trial data (SDGR:NASDAQ) - Seeking Alpha
Transcript : Schrödinger, Inc.Special Call - MarketScreener
Schrodinger (SDGR) Reports Promising Phase 1 Results of SGR-1505 | SDGR Stock News - GuruFocus
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress - Eagle-Tribune
Day 9 of Gains Streak for Schrodinger Stock with 24% Return (vs. 38% YTD) [6/11/2025] - Trefis
Schrodinger Inc (SDGR) Trading 5.17% Higher on Jun 11 - GuruFocus
California State Teachers Retirement System Reduces Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of “Buy” from Analysts - Defense World
Comparing Schrödinger (NASDAQ:SDGR) & Salarius Pharmaceuticals (NASDAQ:SLRX) - Defense World
Schrödinger's Stock in a Quantum State: Fraud Probe and Leadership Shake-Up Cloud the Outlook - AInvest
Schrodinger Inc (SDGR) Trading 4.34% Higher on Jun 6 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Schrodinger Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Shareholders to Connect - ACCESS Newswire
Kalkine NASDAQ 100 Top Stocks Leading Technology Giants Driving Market Growth - Kalkine Media
24,500 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Acquired by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Reduces Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrodinger at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Schrodinger at Jefferies Conference: Strategic Growth and Challenges - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Two Sigma Investments LP Acquires New Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Top 5 AI & Digital Biotech Companies (June 2025) - Securities.io
Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ProShare Advisors LLC Has $323,000 Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer - 01net
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) To Newly Appointed Chief Commercial Officer - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect - ACCESS Newswire
Schrodinger appoints Mannix Aklian as chief commercial officer - TipRanks
Schrödinger Appoints Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - citybiz
3.57%
7.93%
자본화:
|
볼륨(24시간):